Atara Biotherapeutics (ATRA) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 1.79 |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | -1.18 |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 0.05 |
| 8 | Sarepta Therapeutics | 2.14 Bn | 1.35 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.93 Bn | 1.76 Bn | 56.40 Mn | 0.04 |
| 10 | Atara Biotherapeutics | 146.20 Mn | 129.64 Mn | 439,000.00 | -0.32 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.32 |
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.80 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | 3.50 |
| Dec 31, 2024 | -1.70 |
| Sep 30, 2024 | -2.93 |
| Jun 30, 2024 | -3.10 |
| Mar 31, 2024 | -5.65 |
| Dec 31, 2023 | -14.33 |
| Sep 30, 2023 | -16.40 |
| Jun 30, 2023 | -16.92 |
| Mar 31, 2023 | -17.98 |
| Dec 31, 2022 | -18.30 |
| Sep 30, 2022 | -20.53 |
| Jun 30, 2022 | 4.53 |
| Mar 31, 2022 | -21.87 |
| Dec 31, 2021 | -24.97 |
| Sep 30, 2021 | -22.61 |